Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.5M
-
Number of holders
-
174
-
Total 13F shares, excl. options
-
18.7M
-
Shares change
-
+460K
-
Total reported value, excl. options
-
$868M
-
Value change
-
+$20.8M
-
Put/Call ratio
-
0
-
Number of buys
-
86
-
Number of sells
-
-82
-
Price
-
$46.47
Significant Holders of LEMAITRE VASCULAR INC - Common Stock (LMAT) as of Q1 2022
204 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock as of Q1 2022.
LEMAITRE VASCULAR INC - Common Stock (LMAT) has 174 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.7M shares
of 22.5M outstanding shares and own 83.05% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.18M shares), Conestoga Capital Advisors, LLC (1.88M shares), VANGUARD GROUP INC (1.43M shares), Copeland Capital Management, LLC (1.22M shares), GENEVA CAPITAL MANAGEMENT LLC (867K shares), STATE STREET CORP (710K shares), DIMENSIONAL FUND ADVISORS LP (689K shares), Ranger Investment Management, L.P. (670K shares), KENNEDY CAPITAL MANAGEMENT, INC. (402K shares), and Summit Creek Advisors LLC (364K shares).
This table shows the top 174 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.